Crossmark

Coronary Artery Calcium Scoring in the Context of Widespread Lipoprotein(a) Testing: Clinical Considerations and Implications for Lipid-Lowering Therapies

Crossref DOI link: https://doi.org/10.1007/s11886-025-02210-1

Published Online: 2025-02-11

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Palanisamy, Srikanth

Burka, Semenawit

Blaha, Michael J.
License Information

Text and Data Mining valid from 2025-02-11

Version of Record valid from 2025-02-11
More Information

Article History

Accepted: 30 January 2025

First Online: 11 February 2025

Declarations

:

: Full disclosures are in the mansucript. MJB declares that he has served on an Advisory Board for Novartis and Eli Lilly.

: No animal or human subjects by the authors were used in this study.

Document is current

Any future updates will be listed below